Oct 7, 2026

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics:

• Case: A woman in her mid 60s with Stage II uterine carcinosarcoma treated with surgery followed by paclitaxel/carboplatin, whole-pelvic radiation and vaginal...

Oct 1, 2026

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics:

• Case: A woman in her mid 60s with metastatic serous endometrial carcinoma that is HER2 IHC 3+ who received first-line carboplatin/paclitaxel/trastuzumab and second-line...

Sep 30, 2026

Featuring perspectives from Dr Shannon N Westin and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:

• Introduction (0:00)
• Ovarian Cancer (2:22)
• Endometrial Cancer (37:48)

CME information and select...

Sep 29, 2026

Featuring an interview with Professor Nicoletta Colombo, including the following topics:

• Mechanistic effects and rationale underlying the use of relacorilant/nab paclitaxel (0:00)
• Rationale underlying the study design of the Phase II BELLA trial and avenues for future exploration (8:31)
• Definition of platinum...

Sep 29, 2026

Featuring a slide presentation and related discussion from Professor Nicoletta Colombo, including the following topics:

• Rationale for targeting the glucocorticoid receptor; relacorilant mechanism of action (0:00)
• Key efficacy and safety findings from a Phase II study of relacorilant/nab paclitaxel for...